β-amyloid-associated free radical oxidative stress and neurotoxicity: Implications for Alzheimer's disease

Chemical Research in Toxicology

Volumn 10, Issue 5, 1997, Pages 495-506

  Butterfield, D Allan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; FREE RADICAL; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL DAMAGE; CONTROLLED STUDY; DEMENTIA; HIPPOCAMPUS; LIPID PEROXIDATION; MOUSE; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PAIRED HELICAL FILAMENT; REVIEW; SENILE PLAQUE; SYNAPSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; OXIDATIVE STRESS;

ANIMALIA;

EID: 0030928406     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx960130e     Document Type: Review

References (113)

1. Alzheimer, L. (1907) Uber eine eigenartige erkraankung der hirnrince. Centralblatt Nervenheil Kunde Psychiat. 30, 177-179.
2. Katzman, R., and Saitoh, T. (1991) Advances in Alzheimer's Disease. FASEB J. 4, 278-286.
3. Scheff, S. W., and Price, D. A. (1993) Synapse Loss in Temporal Lobe in Alzheimer's Disease. Ann. Neurol. 33, 190-199.
4. Butterfield, D. A., Hensley, K., Hall, N., Subramaniam, R., Howard, B. J., Cole, P., Yatin, S., Lafontaine, M., Harris, M. E., Aksenova, M., Aksenov, M., and Carney, J. (1996) β-Amyloid-derived free radical oxidation: a fundamental process in Alzheimer's disease. In Molecular Models of Dementia (Wasco, W., and Tanzi, R., Eds.) pp 145-167, Humana Press, Totowa, NJ.
5. Hensley, K., Butterfield, D. A., Hall, N., Cole, P., Subramaniam, R., Mark, R., Mattson, M. P., Markesbery, W. R., Harris, M. E., Aksenov, M., Aksenova, M., Wu, J. F., and Carney, J. M. (1996) Reactive Oxygen Species as Causal Agents in the Neurotoxicity of the Alzheimer's Disease-Associated Amyloid Beta Peptide. Ann. N. Y. Acad. Sci. 786, 120-134.
6. Butterfield, D. A. (1996) Alzheimer's disease: A disorder of oxidative stress. Alzheimer's Dis. Rev. 1, 68-70.
7. Butterfield, D. A. (1997) Alzheimer's amyloid β-peptide and free radical oxidative stress. In Reactive Oxygen Species in Biological Systems: An Interdisciplinary Approach (Gilbert, D. L., and Colton, C. A., Eds.) Plenum Press, New York, in press.
8. Butterfield, D. A., Subramaniam, R., Cole, P. S., Yatin, S., Hensley, K., Hall, N. C., and Carney, J. M. (1997) Electron paramagnetic resonance studies of amyloid β-peptide- and ischemia/reperfusion-associated free radicals and the membrane damage they cause: Relevance to Alzheimer's disease and stroke. In Oxygen Radicals and the Disease Process (Thomas, C. E., and Kalyanaraman, B., Eds.) Harwood Academic Publishers, Reading, Great Britain, in press.
9. Yan, S. D., Chen, X., Schmidt, A.-M., Brett, J., Godman, G., Zou, Y.-S., Scott, C. W., Caputo, C., Frappier, T., Smith, M. A., Perry, M. A., Yen, S. H., and Stern, D. (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. U.S.A. 91, 7787-7791.
10. Halliwell, B., and Gutteridge, J. M. C. (1989) Free Radicals in Biology and Medicine, Clarendon Press, Oxford.
11. Selkoe, D. J. (1996) Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271, 18295-18298.
12. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagoplan, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masliah, E., McConlogue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, F., Vital, J., Wadsworth, S., Wolozin, B., and Zhao, J. (1995) Alzheimer-Type Neuropathology in Transgenic Mice Overexpress-ing V717F β-Amyloid Precursor Protein. Nature 373, 523-527.
13. Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, P., Wu, J. F., Carney, J. M., Lovell, M., Markesbery, W. R., and Butterfield, D. A. (1995) Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation. J. Neurochem. 65, 2146-2156.
14. Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., and Butterfield, D. A. (1994) A Model for β-Amyloid Aggregation and Neurotoxicity Based of Free Radical Generation by the Peptide: Relevance to Alzheimer Disease. Proc. Natl. Acad. Sci. U.S.A. 91, 3270-3274.
15. Butterfield, D. A., Hensley, K., Harris, M., Mattson, M. P., and Carney, J. M. (1994) β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer's Disease. Biochem. Biophys. Res. Commun. 200, 710-715.
16. Hensley, K., Aksenova, M., Carney, J. M., and Butterfield, D. A. (1995) Amyloid β-Peptide Spin Trapping I: Enzyme Toxicity is Related to Free Radical Spin Trap Reactivity. NeuroReport 6, 489-493.
17. Hensley, K., Aksenova, M., Carney, J. M., and Butterfield, D. A. (1995) Amyloid β-Peptide Spin Trapping II: Evidence for Decomposition of the PBN Spin Adduct. NeuroReport 6, 493-496.
18. Harris, M. E., Hensley, K., Butterfield, D. A., Leedle, R. E., and Carney, J. M. (1995) Direct Evidence of Oxidative Injury by the Alzheimer's Amyloid β Peptide in Cultured Hippocampal Neurons. Exp. Neurol. 131, 193-202.
19. Mark, R. J., Hensley, K., Butterfield, D. A., and Mattson, M. P. (1995) Amyloid β-Peptide Impairs Ion-Motive ATPase Activities: Evidence for a Role in Loss of Neuronal Ca2+ Homeostasis and Cell Death. J. Neurosci. 15, 6239-6249.
20. Subramaniam, R., Howard, B. J., Hensley, K., Aksenova, M., Carney, J. M., and Butterfield, D. A. (1995) β-Amyloid (32-35) Generates Reactive Free Radicals That are Toxic to Biomolecules: Implications to Alzheimer's Disease. Alzheimer's Res. 1, 141-144.
21. 2+, Nitroxide Spin Probes, and Synaptosomal Membrane Proteins. Life Sci. 58, 217-228.
22. Harris, M. E., Carney, J. M., Cole, P., Hensley, K., Howard, B. J., Martin, L., Bummer, P., Wang, Y., Pedigo, N., and Butterfield, D. A. (1995) β-Amyloid Peptide-Derived, Oxygen-Dependent Free Radicals Inhibit Glutamate Uptake in Cultured Astrocytes: Implications to Alzheimer's Disease. NeuroReport 6, 1875-1879.
23. +-dependent glutamate uptake in rat hippocampal astrocyte cultures. J. Neurochem. 67, 277-286.
24. Bruce, A. J., Malfroy, B., and Baudry, M. (1996) β-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. Natl. Acad. Sci. U.S.A. 93, 2312-2316.
25. Tomiyama, T., Shoji, A., Kataoka, K.-I., Suwa, Y., Asano, S., Kaneko, H., and Endo, N. (1996) Inhibition of amyloid β protein aggregation and neurotoxicity by rifampicin. J. Biol. Chem. 271, 6839-6844.
26. Manelli, A. M., and Puttfarcken, P. S. (1995) β-amyloid-induced toxicity in rat hippocampal cells: In vitro evidence for the involvement of free radicals. Brain Res. Bull. 38, 569-576.
27. Puttfarcken, P. S., Manelli, A. M., Neilly, J., and Frail, D. E. (1996) Inhibition of age-induced β-amyloid neurotoxicity in rat hippocampal cells. Exp. Neurol. 138, 73-81.
28. Goodman, Y., Bruce, A. J., Cheng, B., and Mattson, M. P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid-β toxicity in hippocampal neurons. J. Neurochem. 66, 1836-1844.
29. Kelly, J., Furukawa, K., Barger, S. W., Mark, R. J., Rengen, M. R., Roth, G., and Mattson, M. P. (1996) Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons: involvement of free radicals. Proc. Natl. Acad. Sci. U.S.A. 93, 6753-6758.
30. Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., and Mattson, M. P. (1997) Evidence that 4-hydroxynonenal mediates disruption of ion homeostasis and neuronal death by amyloid-β peptide. J. Neurochem. 68, 255-264.
31. Behl, C., Davis, J. B., Lesley, R., and Shubert, D. (1994) Hydrogen Peroxide Medicates Amyloid β Protein Toxicity. Cell 77, 817-827.
32. Smith, M. A., Taneda, S., Richey, P. L., Mikyata, S., Yan, S., Stern, D., Sayer, L., Monnier, V. M., and Perry, G. (1994) Advanced Maillard Reaction End Products Are Associated with Alzheimer Disease Pathology. Proc. Natl. Acad. Sci. U.S.A. 91, 5710-5714.
33. Smith, M. A., Sayre, L. M., Monnier, V. A., and Perry, G. (1995) Radical AGEing in Alzheimer's disease. Trends Neurosci. 18, 172-176.
34. Markesbery, W. R., Lovell, M. A., and Ehmann, W. D. (1994) Brain Trace Metals in Alzheimer Disease. In Alzheimer Disease (Terry, R. D., Katzman, R., and Bick, K. L., Eds.) pp 353-367, Raven Press, New York.
35. Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C. L., and Beyreuther, K. (1996) The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I). Science 271, 1406-1409.
36. Parker, W. D., Jr., Parks, J., Filley, C. M., and Kleinschmidt-Demasters, B. K. (1994) Electron Transport Chain Defects in Alzheimer's Disease Brain. Neurology 44, 1090-1096.
37. Nutisya, E. M., Bowling, A. C., and Beal, M. F. (1994) Cortical Cytochrome Oxidase Activity is Reduced in Alzheimer's Disease. J. Neurochem. 63, 2179-2184.
38. Colton, C. A., Snell, J., Chernyshev, O., Gilbert, D. L. (1994) Induction of Superoxide Anion and Nitric Oxide Production in Cultured Microglia. Ann. N.Y. Acad. Sci. 738, 54-63.
39. Pappolla, M. A., Omar, R. A., Kim, K. S., and Robakis, N. K (1992) Immunohistochemical evidence of antioxidant stress in Alzheimer's disease. Am. J. Pathol. 140, 621-628.
40. Estevez, A. G., Radi, R., Barbeito, L., Shin, J. T., Thompson, J. A., and Beckman, J. S. (1995) Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J. Neurochem. 65, 1543-1550.
41. 2+], and neurotoxicity, and increase in antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65, 1740-1751.
42. Lafon-Cazal, M., Pietri, S., Culcasi, M., and Bockaert, J. (1992) NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535-537.
43. Whittemore, E. R., Loo, D. T., Watt, J. A., and Cotman, C. W. (1995) A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture. Neuroscience 67, 921-932.
44. Simonian, N. A., and Coyle, J. T. (1996) Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36, 83-106.
45. Selkoe, D. J. (1994) Alzheimer's Disease: A Central Role of Amyloid. J. Neuropathol. Exp. Neurol. 53, 438-447.
46. Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. (1993) Neurodegeneration Induced by β-Amyloid Peptides in Vitro: Role of Peptide Assembly State. J. Neurosci. 13, 1676-1687.
47. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henshen, A., Yates, J., Cotman, C., and Glabe, C. (1992) Assembly and Aggregation Properties of Synthetic Alzheimer's A4/B-Amyloid Peptide Analogs. J. Biol. Chem. 267, 546-554.
48. Lorenzo, A., and Yankner, B. A. (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. U.S.A. 91, 12243-12247.
49. Oda, T., Wals, P., Osterbung, H., Johnson, S., Pasinetti, G., Morgan, T., Rozovosky, I., Stein, W. B., Synder, S., Holzman, T., Krafft, G., and Finch, C. (1995) Clusterin (apo J) alters the aggregation of amyloid β peptide (Aβ 1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress. Exp. Neurol. 136, 22-31.
50. Smith-Swintosky, V. L., Zimmer, S., Fenton, J. W., and Mattson, M. P. (1995) Opposing actions of thrombin and protease nexin-1 on amyloid β-peptide toxicity and on accumulation of peroxides and calcium in hippocampal neurons. J. Neurochem. 65, 1415-1418.
51. Aksenov, M. Y., Aksenova, M. V., Harris, M. E., Hensley, K., Butterfield, D. A., and Carney, J. M. (1995) Enhancement of Aβ-(1-40) neurotoxicity by glutamine synthetase. J. Neurochem. 65, 1899-1902.
52. Aksenov, M. Y., Aksenova, M. V., Butterfield, D. A., Hensley, K., Vigo-Pelfrey, C., and Carney, J. M. (1996) Glutamine synthetase-induced enhancement of β-amyloid peptide Aβ(1-40) neurotoxicity accompanied by abrogation of fibril formation and Aβ fragmentation. J. Neurochem. 66, 2050-2056.
53. Aksenova, M. V., Aksenov, M. Y., Butterfield, D. A., and Carney, J. M. (1996) Alpha 1-antichymotrypsin interaction with Aβ(1-40) inhibits fibril formation but does not affect the peptide toxicity. Neurosci. Lett. 211, 45-48.
54. Aksenov, M., Aksenova, M., Carney, J. M., and Butterfield, D. A. (1996) Alpha 1-antichymotrypsin interaction with Aβ(1-42) does not inhibit fibril formation but attenuates the peptide toxicity. Neurosci. Lett. 217, 117-120.
55. Yankner, B. A., Duffy, L. K., and Kirschnier, D. A. (1990) Neurotrophic and Neurotoxic Effects of Amyloid β-Protein: Reversal by Tachykinin Neuropeptides. Science 250, 279-282.
56. Jarrett, J. T., Berber, E. P., and Lansbury, P. T. (1993) The Carboxy Terminus of the β-Amyloid Protein is Critical in the Seeding of Amyloid Formation: Implications for the Pathogenesis of Alzheimer's Disease. Biochemistry 32, 4693-4697.
57. Jarrett, J. T., and Lansbury, P. T. (1993) One-Dimensional Crystallization of Amyloid: A Pathogenic Mechanism in Alzheimer's Disease? Cell 73, 1053-1058.
58. Tomski, S., and Murphy, R. M. (1992) Kinetics of Aggregation of Synthetic β-Amyloid Peptides. Arch. Biochem. Biophys. 294, 630-638.
59. 2+ Homeostasis Alzheimer's Disease. Trends Neurosci. 16, 409-414.
60. Goodman, Y., Steiner, M. R., Steiner, S. M., and Mattson, M. P. (1994) Nordihydroguaiaretic Acid Protects Hippocampal Neurons Against Amyloid β-Peptide Toxicity, and Attenuates Free Radical and Calcium Accumulation. Brain Res. 654, 171-176.
61. + channel openers protect hippocampal neurons against oxidative injury and amyloid-β toxicity. Brain Res. 706, 328-332.
62. Goodman, Y., and Mattson, M. P. (1994) Staurosporine and K-252 Compounds Protect Hippocampal Neurons Against Amyloid β-Peptide Toxicity and Oxidative Injury. Brain Res. 650, 170-174.
63. Goodman, Y., and Mattson, M. P. (1994) Secreted Forms of β-Amyloid Precursor Protein Protect Hippocampal Neurons Against Amyloid β-Peptide-Induced Oxidative Injury. Exp. Neurol. 128, 1-12.
64. Kumar, U., Dunlop, D. M., and Richardson, J. S. (1994) The Acute Neurotoxic Effect of β-Amyloid on Mature Cultures of Rat Hippocampal Neurons is Attenuated by the Antioxidant U-78517F. Int. J. Neurosci. 79, 185-190.
65. Goodman, Y., and Mattson, M. P. (1996) Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J. Neurochem. 66, 869-872.
66. Janzen, E. G. (1980) A critical review of spin trapping in biological systems. In Free Radicals in Biology (Pryo, W. A., Ed.) pp 115-154, Vol. 4, Academic Press, New York.
67. Butterfield, D. A. (1986) Spectroscopic methods in degenerative neurological diseases. Crit. Rev. Neurobiol. 2, 169-240.
68. Butterfield, D. A. (1982) Spin labeling in disease. Biol. Magn. Reson. 4, 1-78.
69. Chan, W. K. M., Decker, E. A., Lee, J., and Butterfield, D. A. (1994) EPR Spin Trapping Studies of the Hydroxyl Radical Scavenging Activity of Carnosine and Related Dipeptides. J. Agric. Food Chem. 42, 1407-1410.
70. Clerici, W. J., Hensley, K., DiMartino, D. L., and Butterfield, D. A. (1996) Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hearing Res. 98, 116-124.
71. Faller, B., and Hanspeter, N. (1994) Kinetics and mechanism of iron(III) removal from citrate by desferrioxamine B and 3-hydroxy-1,2-dimethyl-4-pyridone. J. Am. Chem. Soc. 116, 3860-3865.
72. Janzen, E. G., Krygsman, P. H., Lindsay, D. A., and Haire, D. L. (1990) Detection of alkyl, alkoxyl, and alkylperoxyl radicals from the thermolysis of azobis(isobutyronitrile) by ESR/spin trapping: evidence for double spin adducts from liquid-phase chromatography and mass spectroscopy. J. Am. Chem. Soc. 112, 8279-8284.
73. May, P. C., Gitter, B. D., Waters, D. C., Simmons, L. K., Becker, G. W., Small, J. S., and Robinson, P. M. (1992) β-Amyloid Peptide in Vitro Toxicity: Lot-to-lot Variability. Neurobiol. Aging 13, 605-607.
74. Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I., Becker, G. W., Brems, D. N., and Li, W. Y. (1994) Secondary Structure of Amyloid β Peptide Correlates with Neurotoxic Activity in Vitro. Mol. Pharmacol. 45, 373-79.
75. Soto, C., Golabek, A., Wisniewski, T., and Castano, E. M. (1996) Alzheimer's β-amyloid peptide is conformationally modified by apolipoprotein E in vitro. NeuroReport 7, 721-725.
76. Pike, C. J., Walencewicz-Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., and Cotman, C. W. (1995) Structure-Activity Analyses of β-Amyloid Peptides: Contributions of the β05-35 Region to Aggregation and Neurotoxicity. J. Neurochem. 64, 253-265.
77. Synder, S. W., Ladror, U. S., Wade, W. S., Wang, G. T., Barrett, L. W., Matayoshi, E. D., Huffaker, J. H., Krafft, G. A., and Holzman, T. F. (1995) Amyloid-β Aggregation: Selective Inhibition of Aggregation in Mixtures of Amyloid with Different Chain Lengths. Biophys. J. 67, 1216-1228.
78. Naslund, J., Schierhorn, A., Hellman, U., Lanfelt, L., Roses, A. D., Tjernberg, L. O., Siberring, J., Gandy, S. E., Winblad, B., Greengard, P., Nordstedt, C., and Terenius, L. (1994) Relative Abundance of Alzheimer Aβ Amyloid Peptide Variants in Alzheimer Disease and Normal Aging. Proc. Natl. Acad. Sci. U.S.A. 91, 8378-8382.
79. Sato, K., Wakamiya, A., Maeda, T., Noguchi, K., Takashima, A., and Imahori, K. (1995) Correlation among secondary structure, amyloid precusor protein accumulation, and neurotoxicity of amyloid β(25-35) peptide as analyzed by single alanine substitution. J. Biochem. 118, 1108-1111.
80. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., and Pecerak-Vance, M. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
81. Butterfield, D. A., and Stadtman, E. R. (1997) Protein oxidation processes in aging brain. In The Aging Brain (Mattson, M. P., and Geddes, J. W., Eds.) JAI Press, Greenwich, CT, in press.
82. Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashimia, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., and Schmidt, A. M. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
83. Selkoe, D. J. (1991) The Molecular Pathology of Alzheimer's Disease. Neuron 6, 487-498.
84. Corain, B., Iqbal, K., Nicolini, M., Winblad, B., Wisniewski, H., and Zatta, P., Eds. (1993) Alzheimer's Disease: Advances in Clinical and Basic Research, John Wiley, New York.
85. Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., and Markesbery, W. R. (1991) Excess Brain Protein Oxidation and Enzyme Dysfunction in Normal Aging and Alzheimer Disease. Proc. Natl. Acad. Sci. U.S.A. 88, 10540-10543.
86. Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Landum, R. W., Cheng, M., Wu, J. F., and Floyd, R. A. (1991) Reversal of Age-Related Increase in Brain Protein Oxidation, Decrease in Enzyme Activity, and Loss in Temporal and Spatial Memory by Chronic Administration of the Spin-Trapping Compound N-tert-butyl-α-Phenylnitrone. Proc. Natl. Acad. Sci. U.S.A. 88, 3633-3636.
87. Smith, C. D., Carney, J. M., Tatsumo, T., Stadtman, E. R., Floyd, R. A., and Markesbery, W. R. (1992) Protein Oxidation in Ageing Brain. Ann. N. Y. Acad. Sci. 663, 110-119.
88. Starke-Reed, P. E., and Oliver, C. N. (1989) Protein Oxidation and Proteolysis During Aging and Oxidative Stress. Arch. Biochem. Biophys. 275, 559-567.
89. Prusiner, S. B. (1992) Biology and Genetics of Prion Diseases. Biochemistry 31, 12277-12288.
90. Kang, J., Lemair, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeshik, K. H., Multhaup, G., Beyreuther, K., and Müller-Hill, B. (1987) The Precursor of Alzheimer' Disease A4 Protein Resembles a Cell-Surface Receptor. Nature 325, 733-736.
91. Mason, R. P., Estermyer, J. D., Kelly, J. F., and Mason, P. E. (1996) Alzheimer's disease amyloid β peptide 25-35 is localized in the membrane hydrocarbon core: x-ray diffraction analysis. Biochem. Biophys. Res. Commun. 222, 78-82.
92. Subramaniam, R., Roediger, F., Jordan, B., Mattson, M. P., Keller, J. N., Waeg, G., and Butterfield, D. A. (1997) The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters conformation of cortical synaptosomal membrane products. J. Neurochem., in press.
93. Stadtman, E. R. (1992) Protein oxidation and aging. Science 257, 1220-1224.
94. Umhauer, S. A., Isbell, B. I., and Butterfield, D. A. (1992) Spin Labeling or Membrane Proteins in Mammalian Brain Synaptic Plasma Membranes: Partial Characterization. Anal. Lett. 25, 1201-1215.
95. Hensley, K., Hall, N., Shaw, W., Carney, J. M., and Butterfield, D. A. (1994) Electron Paramagnetic Resonance Investigation of Free Radical Induced Alterations in Neocortical Synaptosomal Membrane Protein Infrastructure. Free Radical Biol. Med. 17, 321-331
96. Hall, N. C., Carney, J. M., Cheng, M. S., and Butterfield, D. A. (1995) Ischemia/Reperfusion Induced Changes in Membrane Proteins and Lipids of Gerbil Cortical Synaptosomes. Neuroscience 64, 81-89.
97. Hall, N. C., Carney, J. M., Cheng, M., and Butterfield, D. A. (1995) Prevention of Ischemia/Reperfusion-Induced Alterations in Synaptosomal Membrane-Associated Proteins and Lipids by N-tert-butyl-α-phenylnitrone and Difluoromethylornithine. Neuroscience 69, 591-600.
98. Hall, N. C., Dempsey, R. J., Carney, J. M., Donaldson, D. L., and Butterfield, D. A. (1995) Structural Alterations in Synaptosomal Membrane-Associated Proteins and Lipids by Transient Middle Cerebral Artery Occlusion in the Cat. Neurochem. Res. 20, 1161-1169.
99. Hall, N. C., Carney, J. M., Plante, O. J., Cheng, M., and Butterfield, D. A. (1997) Effect of 2-cyclohexene-1-one-induced glutathione diminution on ischemia/reperfusion-induced alterations in the physical state of brain synaptosomal membrane proteins and lipids. Neuroscience 77, 283-290.
100. Bellary, S. S., Anderson, K. W., Arden, W. A., and Butterfield, D. A. (1995) Effect of Lipopolysaccharide on the Physical Conformation of the Erythrocyte Cytoskeletal Proteins. Life Sci. 56, 91-98.
101. Trad, C. H., and Butterfield, D. A. (1994) Menadione Induced Cytotoxicity Effects of Human Erythrocyte Membranes Studies by Electron Paramagnetic Resonance. Toxicol. Lett. 73, 145-155.
102. Hensley, K., Howard, B. J., Carney, J. M., and Butterfield, D. A. (1995) Membrane protein alterations in rodent erythrocytes and synaptosomes due to aging and hyperoxia. Biochim. Biophys. Acta 1270, 203-206.
103. Howard, B. J., Yatin, S., Hensley, K., Allen, K. L., Kelly, J. P., Carney, J., and Butterfield, D. A. (1996) Prevention of hyperoxia-induced alterations in synaptosomal membrane-associated proteins by N-tert-butyl-α-phenylnitrone (PBN) and 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol). J. Neurochem. 67, 2045-2050.
104. Butterfield, D. A., Howard, B. J., Yatin, S., Allen, K. L., and Carney, J. M. (1997) Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-α-phenylnitrone. Proc. Natl. Acad. Sci. U.S.A. 94, 674-678.
105. Volterra, A., Trotti, D., Tromba, C., Floridi, S., and Racagni, G. (1994) Glutamate Uptake Inhibition by Oxygen Free Radicals in Rat Cortical Astrocytes. J. Neurosci. 14, 2924-2932.
106. Gunnersen, D., and Haley, B. (1992) Detection of Glutamine Synthetase in the Cerebrospinal Fluid of Alzheimer Diseased Patients: A Potential Diagnostic Marker. Proc. Natl. Acad. Sci. U.S.A. 89, 11949-11953.
107. Trad, C. H., James, W., Bhardwaj, A., and Butterfield, D. A. (1995) Selective Labeling of Membrane Protein Sulfhydryl Groups with Methanethiosulfonate Spin Label. J. Biochern. Biophys. Methods 30, 287-299.
108. Butterfield, D. A., Lee, J., Ganapathi, S., and Bhattacharyya, D. (1994) Biofunctional Membranes IV. Active Site Structure and Stability of an Immobilized Enzyme, Papain, on Modified Polysulfone Membranes Studied by Electron Paramagnetic Resonance and Kinetics. J. Membr. Sci. 91, 47-64.
109. Butterfield, D. A., and Lee, J. (1994) Active Site Structure and Stability of the Thiol Protease, Papain, Studied by Electron Paramagnetic Resonance Employing a Methanethiosulfonate Spin Label. Arch. Biochem. Biophys. 310, 167-171.
110. Bhardwaj, A., Lee, J., Glauner, K., Ganapathi, S., Bhattacharyya, D., and Butterfield, D. A. (1996) Biofunctional membranes: an EPR study of active site structure and stability of papain non-covalently immobilized on the surface of modified poly(ether)sulfone membranes through the avidin-biotin linkage. J. Membr. Sci. 119, 241-252.
111. Subramaniam, R., Cole, P., Hensley, K., Azhar, S., Bummer, P., Carney, J. M., and Butterfield, D. A. (1996) Effects of oxidative stress on the model thiol protease - papain: an investigation of changes in activity and structure. Biochem. Arch. 12, 105-116.
112. Butterfield, D. A., Hensley, K., Cole, P., Subramaniam, R., Aksenov, M., Aksenova, M., Bummer, P. M., Haley, B. E., and Carney, J. M. (1997) Oxidatively-induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. J Neurochem., in press.
113. Lockhart, B. P., Benicourt, C., Junien, J.-L., and Privat, A. (1994) Inhibitors of free radical formation fail to attenuate direct β-amyloid 25-35 peptide-mediated neurotoxicity in rat hippocampal cultures. J. Neurosci. Res. 39, 494-505.